Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT?
Alpha Vantage · The Motley Fool · · AI-summarised by FinFlash
This article compares two healthcare ETFs: State Street SPDR S&P Pharmaceuticals ETF (XPH) and First Trust NYSE Arca Biotechnology Index Fund (FBT). XPH offers broader exposure to pharmaceutical companies with a lower expense ratio and a small dividend, making it suitable for long-term core holdings.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.